Medidata Solutions (Nasdaq:

) today announced that Denmark-based H. Lundbeck A/S has extended its agreement to use the Medidata Rave(R) electronic data capture (

) and clinical data management (CDM) platform for another multi-year period, building on the success of the relationship in the initial three-year contract. Lundbeck is one of Denmark's most research-intensive enterprises, focuses on therapies for central nervous system (

) disorders, including depression and anxiety, schizophrenia, insomnia, Huntington's, Alzheimer's and Parkinson's diseases.